Pharmhouse Corp (PHSE) — Cash Flow-to-Debt Ratio
Pharmhouse Corp (PHSE) has a Cash Flow-to-Debt Ratio of -12.79x as of September 2025, meaning its operating cash flow of $-27.11 Million could theoretically repay -13% of its total liabilities ($2.12 Million) in one year. See Pharmhouse Corp free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharmhouse Corp Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Pharmhouse Corp across 8 annual periods. Also explore how fast is Pharmhouse Corp growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pharmhouse Corp (1996–2024)
Year-by-year debt coverage analysis for Pharmhouse Corp. For market capitalisation and broader financial context, see PHSE company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.36x | $-614.75K | $1.72 Million | ▼ -107.5% |
| 2023 | 4.76x | $1.71 Million | $358.92K | ▲ +960.5% |
| 2021 | -0.55x | $-71.12K | $128.47K | ▲ +92.3% |
| 2020 | -7.20x | $-1.95 Million | $271.45K | ▼ -43170.9% |
| 2019 | 0.02x | $652.00 | $39.00K | ▲ +102.5% |
| 1998 | -0.67x | $-1.93 Million | $2.88 Million | ▼ -88.1% |
| 1997 | -0.36x | $-1.83 Million | $5.13 Million | ▲ +20.7% |
| 1996 | -0.45x | $-2.44 Million | $5.43 Million | — |